Thrombosis

Common Name(s)

Thrombosis

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Thrombosis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Thrombosis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Thrombosis" returned 4321 free, full-text research articles on human participants. First 3 results:

Factor XI antisense oligonucleotide for venous thrombosis.
 

Author(s): Harry R Büller, David Gailani, Jeffrey I Weitz

Journal: N. Engl. J. Med.. 2015 Apr;372(17):1672.

 

Last Updated: 23 Apr 2015

Go To URL
Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS.
 

Author(s): Roxanne Cofiell, Anjli Kukreja, Krystin Bedard, Yan Yan, Angela P Mickle, Masayo Ogawa, Camille L Bedrosian, Susan J Faas

Journal: Blood. 2015 May;125(21):3253-62.

 

Atypical hemolytic uremic syndrome (aHUS) is a genetic, life-threatening disease characterized by uncontrolled complement activation, systemic thrombotic microangiopathy (TMA), and vital organ damage. We evaluated the effect of terminal complement blockade with the anti-C5 monoclonal ...

Last Updated: 22 May 2015

Go To URL
An unusual presentation of venous thrombosis in a child with idiopathic membranous nephropathy.
 

Author(s): Sreekanth Burri, Manjusha Yadla, Pradeep Deshpande, Rama Enaganti, Ramesh Chada, Nimmagadda Laxmi NarasimhaMoorthy, Nethikoppula Anil Kumar

Journal: Saudi J Kidney Dis Transpl. 2015 Mar;26(2):355-8.

 

Venous thrombosis is one of the major complications associated with nephrotic syndrome. Among the primary glomerular diseases, membranous nephropathy is associated with a high incidence of thrombotic events. Although this is well described in adults, there is paucity of the literature ...

Last Updated: 12 Mar 2015

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Thrombosis" returned 493 free, full-text review articles on human participants. First 3 results:

Thrombosis: a major contributor to global disease burden.
 

Author(s):

Journal: Thromb. Res.. 2014 Nov;134(5):931-8.

 

Thrombosis is a common pathology underlying ischemic heart disease, ischemic stroke, and venous thromboembolism (VTE). The Global Burden of Disease Study 2010 (GBD 2010) documented that ischemic heart disease and stroke collectively caused one in four deaths worldwide. GBD 2010 did ...

Last Updated: 2 Dec 2014

Go To URL
[Progress of relationship between complement activation and microvascular thrombosis in thrombotic microangiothies].
 

Author(s): Yinping Meng, Rong Fu

Journal: Zhonghua Xue Ye Xue Za Zhi. 2014 Aug;35(8):767-70.

 

Last Updated: 25 Aug 2014

Go To URL
Clinical, laboratory, and therapeutic analyses of 21 patients with neonatal thrombosis and antiphospholipid antibodies: a literature review.
 

Author(s): Marcus Vinicius da Costa Peixoto, Jozélio Freire de Carvalho, Carlos Ewerton Maia Rodrigues

Journal: J Immunol Res. 2014 ;2014():672603.

 

A review of the literature reports neonatal thrombosis and antiphospholipid antibodies cases through a retrospective study that focuses on the pathogenesis and main clinical and laboratory manifestations of this disease.

Last Updated: 18 Aug 2014

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Anticoagulation Length in Cancer Associated Thrombosis
 

Status: Not yet recruiting

Condition Summary: Cancer; Thrombosis; Venous Thromboembolism; Deep Vein Thrombosis; Pulmonary Embolus

 

Last Updated: 20 Mar 2013

Go to URL
Rosuvastatin for Preventing Deep Vein Thrombosis
 

Status: Recruiting

Condition Summary: Deep Vein Thrombosis; Venous; Thrombosis; Prevention

 

Last Updated: 4 Oct 2011

Go to URL
Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis
 

Status: Recruiting

Condition Summary: Sinus Thrombosis, Intracranial

 

Last Updated: 6 Oct 2014

Go to URL